CSGEF yields 5.62% · JNJ yields 3.36%● Live data
📍 CSGEF pulled ahead of the other in Year 1
Combined, CSGEF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSGEF + JNJ for your $10,000?
China Suntien Green Energy Corporation Limited, together with its subsidiaries, develops and utilizes clean energy in Mainland China. It operates through three segments: Natural Gas, Wind Power and Solar Energy, and Other. The Natural Gas segment sells natural gas and gas appliances, as well as provides construction and connection services for natural gas pipelines. The Wind/Solar Power segment engages in the development, management, and operation of the wind farm and solar power plants; and generates and sells electric power for power grid companies. The Other segment engages in the management and property leasing business. As of December 31, 2021, the company owned 7 long-distance natural gas transmission pipelines, 20 high-pressure branch pipelines, 31 urban gas projects, 25 distribution stations, 19 gate stations, 6 compressed natural gas (CNG) primary filling stations, 3 CNG secondary filling stations, 3 liquefied natural gas filling station, and 2 L-CNG joint filling stations. It also had a wind power consolidated installed capacity of 5,673.85 megawatts (MW) and installed capacity under management of 5,869.45 MW, as well as an attributable installed capacity of 5,311.60 MW. It also engages in the provision of project investment, investment management, and technical development services; and investment and sale of solar energy appliances, as well as provides service consultancy services. Further, it offers operation and maintenance of photovoltaic power stations and logistics, loading and unloading, and transportation services. The company was incorporated in 2010 and is headquartered in Shijiazhuang, the People's Republic of China.
Full CSGEF Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.